Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Shanghai Fosun Pharmaceutical (Group) Co ( (HK:2196) ) has issued an update.
Shanghai Fosun Pharmaceutical has announced the election of Ms. Yan Jia as the employee director for the tenth session of its board. This decision follows a resolution to amend the Articles of Association, allowing employee directors to be elected without shareholder approval, which could enhance employee representation and influence in the company’s governance.
More about Shanghai Fosun Pharmaceutical (Group) Co
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a joint stock limited company based in China, primarily engaged in the pharmaceutical industry. The company focuses on the development, manufacture, and sale of pharmaceutical products and medical devices, with a significant emphasis on innovative drugs.
Average Trading Volume: 5,768,336
Technical Sentiment Signal: Buy
Current Market Cap: HK$67.95B
See more insights into 2196 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue